Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
10 Effective Self-Care Practices for Graduating Students
-
Life360 Announces Launch of U.S. Initial Public Offering
-
Transactions in connection with share buyback programme
-
DefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation
-
Triple Point Resources' Fischells Salt Dome Continues to Prove Ideal for Energy Storage
-
Forum Announces $1,000,000 Private Placement
-
Banyan Commences Drilling and Announces Henry Marsden as Technical Advisor, Aurmac Project, Yukon
-
Zedge To Report Third Fiscal Quarter 2024 Results
-
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader
-
AZZ Inc. Appoints Jason Crawford as Chief Financial Officer
-
Hyatt’s Growth Momentum Continues With Record Global Pipeline of 129,000 Rooms
-
Edwards Lifesciences to Sell Critical Care to BD
-
Organizations With Network Observability Are 3.5X More Likely to Significantly Reduce Detection Times, VIAVI Study Reveals
-
KalVista Pharmaceuticals Presents Data on Persisting Unmet Needs in Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024
-
Denison Announces Completion of Inaugural ISR Field Test Program at Midwest
-
Babcock & Wilcox Signs Agreement to Proceed with Work for Coal-to-Biomass Power Plant Conversion and Carbon Capture Project in Michigan
-
Chatham Lodging Trust Provides Business Update
-
Ault Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to Stockholders
-
HYSTER-YALE, INC. AND HYSTER-YALE MATERIALS HANDLING, INC. UNVEIL NEW LOGOS AS NAME CHANGES GO INTO EFFECT
-
Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia
-
Form 8.3 - Darktrace Plc
-
Changes in the number of own shares held by Aktia Bank Plc
-
Form 8.3 - Hargreaves Lansdown Plc
-
Prepayments, Realkredit Danmark A/S
-
Nereus Finance Integrates LI.FI To Enable Seamless Onboarding
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Successful demonstration of a superconducting circuit for qubit control within large-scale quantum computer systems
-
DirectRx Pharmacy Announces Changes to Executive Leadership Team
-
Worthington Enterprises Completes Acquisition of Hexagon Ragasco
-
SHEIN Launches SHEIN Exchange Resale Platform in Europe and the United Kingdom
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Jack in the Box Announces Continued Florida Expansion with New Franchise Commitments
-
IN8bio Presents Progression-Free Survival Update from Phase 1 Study of INB-200 at 2024 American Society of Clinical Oncology Annual Meeting
-
Fanhua Announces Strategic Partnership with Baidu AI Cloud for Application of Large Model in Insurance Distribution
-
Canter Resources Reports Significant Boron and Lithium Over Two Kilometres in Strike
-
Baselode Mobilizes for Hook's 16,000 Metre Drill Program
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Microsoft Welcomes OneMeta’s Solution to the Growing AppSource Ecosystem
-
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
Gold Mountain Announces Further Debt Settlements and Issuance of Convertible Debenture
-
Bevstack & Bottlecapps: A Landmark Partnership to Revolutionize Direct-to-Consumer E-Commerce for BevAlc Brands
-
Gartner Announces Gartner Marketing Symposium/Xpo in Denver
-
Gold Sino Assets Limited to Invest $50 Million into Gogoro to Continue Expanding its Leadership in Smart Urban Mobility
-
IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study
-
Bio-Thera Solutions Receives Positive CHMP Opinion for Avzivi® (bevacizumab), a Biosimilar Referencing Avastin®
-
PROMINO NUTRITIONAL SCIENCES PROVIDES CORPORATE UPDATE
-
Hollysys Announces Appointment of New Auditor
-
Medicare Fraud Prevention Week Teaches Everyone How to Prevent Fraud
-
Walker & Dunlop Lists Milhaus’ Artistry, Indianapolis’ Iconic Mixed Use Apartment Complex
